Bharat Biotech’s Covaxin approved for phase 2/3 trials on children
Bharat Biotech’s Covaxin approved for phase 2/3 trials on children
Indian Express
0 shares
1 views
You might like
Related news coverage
Bharat Biotech likely to get a pre-qualification approval from WHO by August
IndiaTimes
The company has informed the government that it is currently in the process of submitting documents, particularly regarding..
-
Paediatric trials of Covaxin may begin in June: Bharat Biotech official
IndiaTimes
-
Plea against Covaxin Phase 2/3 trial in children: Delhi HC notice to Centre, Bharat Biotech
Indian Express
-
DGCI gives nod for Covaxin Phase II/III trials on 2-18 year olds
IndiaTimes
-
Covid-19: DCGI approves phase 2, 3 clinical trials of Covaxin on children aged 2 to 18 years
IndiaTimes
Advertisement
More coverage
Bharat Biotech`s Covaxin gets DGCI nod to conduct clinical trials on children above 2 years
Zee News
The national drug regulator said that it has accepted the recommendation of the SEC “after careful examination” and accorded..